60 Degrees Pharmaceuticals (SXTP) Treasury Shares (2023 - 2026)
60 Degrees Pharmaceuticals (SXTP) posted quarterly Treasury Shares of $1.9 million for Q1 2026, up 256.71% year-over-year from $531784.0 in Q1 2025, and little changed quarter-over-quarter from $1.9 million in Q4 2025.
60 Degrees Pharmaceuticals (SXTP) Treasury Shares (2023 - 2026) Analysis & Trends
60 Degrees Pharmaceuticals (SXTP) has reported Treasury Shares for 4 consecutive years, with $1.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Treasury Shares rose 256.71% year-over-year to $1.9 million; the TTM figure through Mar 2026 stood at $1.9 million (up 256.71% YoY), while the FY2025 annual figure was $1.9 million, up 7.47% from the prior year.
- Treasury Shares steadied at $1.9 million in Q1 2026 per SXTP's latest filing, from $1.9 million in the prior quarter.
- Across five years, Treasury Shares topped out at $9.8 million in Q3 2024 and bottomed at $13190.0 in Q4 2023.
- Historically, Treasury Shares has averaged $2.2 million across 4 years, with a median of $905628.5 in 2024.
- Annual changes were most pronounced in 2024 — Treasury Shares soared 3616.11% — and 2025, when it slumped 42.6%.
- 60 Degrees Pharmaceuticals' Treasury Shares stood at $13190.0 in 2023, then soared by 3245.54% to $441277.0 in 2024, then soared by 329.87% to $1.9 million in 2025, then changed by 0.0% to $1.9 million in 2026.
- Business Quant data shows SXTP's Treasury Shares at $1.9 million in Q1 2026, $1.9 million in Q4 2025, and $7.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | 60 Degrees Pharmaceuticals | 3.00 Mn | 1.98 Mn | 56,798.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.90 Mn |
| Mar 31, 2026 | 1.90 Mn |
| Dec 31, 2025 | 1.90 Mn |
| Dec 31, 2025 | 1.90 Mn |
| Sep 30, 2025 | 7.59 Mn |
| Sep 30, 2025 | 7.59 Mn |
| Jun 30, 2025 | 2.13 Mn |
| Jun 30, 2025 | 2.13 Mn |
| Mar 31, 2025 | 531,784.00 |
| Mar 31, 2025 | 531,784.00 |
| Dec 31, 2024 | 441,277.00 |
| Dec 31, 2024 | 441,277.00 |
| Sep 30, 2024 | 9.80 Mn |
| Sep 30, 2024 | 9.80 Mn |
| Jun 30, 2024 | 884,814.00 |
| Jun 30, 2024 | 884,814.00 |
| Mar 31, 2024 | 926,443.00 |
| Mar 31, 2024 | 926,443.00 |
| Dec 31, 2023 | 13,190.00 |
| Dec 31, 2023 | 13,190.00 |